Pharma major GlaxoSmithKline posted Rs.96 crore net profit for second quarter of 2015-16 as against Rs.129 crore in like period year ago, registering a 26 percent decline.
In a regulatory filing to the Bombay Stock Exchange (BSE) on Saturday, the city-based company said its total income also declined 6.5 percent to Rs. 731 crore in the quarter under review (Q2) from Rs.782 crore in same period last year.
